Related Experiment Video
Updated: Jan 27, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Abstract:
Findings from the ENCORE-601 trial's melanoma cohort show that the experimental HDAC inhibitor entinostat is well tolerated and, together with pembrolizumab, induces durable responses in patients whose disease has progressed on PD-1 blockade alone.
Insights
The HDAC inhibitor entinostat combined with pembrolizumab shows good tolerability and durable responses in melanoma patients who progressed on PD-1 blockade alone. This combination offers a new treatment option for advanced melanoma.
Area of Science:
- Oncology
- Immunotherapy
- Epigenetics
Background:
- The ENCORE-601 trial investigated entinostat, an experimental histone deacetylase (HDAC) inhibitor, in combination with pembrolizumab.
- The study focused on a cohort of patients with advanced melanoma whose disease had progressed despite prior PD-1 blockade therapy.
Discussion:
- Entinostat demonstrated a favorable safety profile when administered with pembrolizumab.
- The combination therapy led to durable clinical responses in a significant portion of the patient population.
- This suggests a potential synergistic effect between HDAC inhibition and PD-1 blockade in overcoming resistance.
Key Insights:
- The combination of entinostat and pembrolizumab is well-tolerated in patients with advanced melanoma.
- Durable responses were observed in patients who had previously progressed on PD-1 inhibitors.
- Entinostat may re-sensitize tumors to PD-1 blockade, offering a new therapeutic strategy.
Outlook:
- Further investigation into the mechanisms of action and predictive biomarkers is warranted.
- This combination could represent a promising new treatment paradigm for refractory melanoma.
- Clinical development of entinostat in combination with immunotherapy is ongoing.
Related Concept Videos
Tumor Immunotherapy
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...

